Baxter Bros Inc Edwards Lifesciences Corp Transaction History

Baxter Bros Inc

$762 Million
Q3 2024

A detailed history of Baxter Bros Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Baxter Bros Inc holds 85,268 shares of EW stock, worth $5.78 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

85,268

Previous 83,758 1.8%

Holding current value

$5.78 Million

Previous $7.74 Million 27.28%

% of portfolio

0.74%

Previous 1.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$59.7 - $93.78 $90,147 - $141,607	1,510 Added 1.8%	85,268 $5.63 Million
Q2 2024 Jul 15, 2024	SELL	$84.3 - $94.31 $274,902 - $307,544	-3,261 Reduced 3.75%	83,758 $7.74 Million
Q1 2024 Apr 26, 2024	SELL	$72.54 - $95.56 $255,558 - $336,657	-3,523 Reduced 3.89%	87,019 $8.32 Million
Q4 2023 May 17, 2024	BUY	$61.71 - $77.76 $215,553 - $271,615	3,493 Added 4.01%	90,512 $6.9 Million
Q4 2023 Feb 06, 2024	BUY	$61.71 - $77.76 $369,334 - $465,393	5,985 Added 7.08%	90,542 $6.9 Million
Q3 2023 May 17, 2024	SELL	$69.28 - $93.38 $172,645 - $232,702	-2,492 Reduced 2.86%	84,527 $5.86 Million
Q3 2023 Oct 23, 2023	BUY	$69.28 - $93.38 $232,434 - $313,289	3,355 Added 4.13%	84,557 $5.86 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $72,210 - $83,670	-887 Reduced 1.08%	81,202 $7.66 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $27,401 - $31,184	-369 Reduced 0.45%	82,089 $6.79 Million
Q4 2022 Jan 31, 2023	SELL	$68.3 - $87.44 $148,211 - $189,744	-2,170 Reduced 2.56%	82,458 $6.15 Million
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $205,513 - $267,688	-2,495 Reduced 2.86%	84,628 $6.99 Million
Q2 2022 Jul 25, 2022	SELL	$86.5 - $128.27 $144,022 - $213,569	-1,665 Reduced 1.88%	87,123 $8.29 Million
Q1 2022 Apr 20, 2022	SELL	$101.96 - $128.34 $67,293 - $84,704	-660 Reduced 0.74%	88,788 $10.5 Million
Q4 2021 Jan 14, 2022	SELL	$106.37 - $130.68 $107,965 - $132,640	-1,015 Reduced 1.12%	89,448 $11.6 Million
Q3 2021 Oct 25, 2021	SELL	$102.91 - $122.75 $220,741 - $263,298	-2,145 Reduced 2.32%	90,463 $10.2 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $33,787 - $42,218	403 Added 0.44%	92,608 $9.59 Million
Q1 2021 Apr 23, 2021	SELL	$78.68 - $90.67 $372,943 - $429,775	-4,740 Reduced 4.89%	92,205 $7.71 Million
Q4 2020 Jan 25, 2021	SELL	$71.69 - $91.23 $262,026 - $333,445	-3,655 Reduced 3.63%	96,945 $8.84 Million
Q3 2020 Nov 05, 2020	SELL	$67.19 - $87.44 $213,664 - $278,059	-3,180 Reduced 3.06%	100,600 $8.03 Million
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $3.94 Million - $5.27 Million	68,430 Added 193.58%	103,780 $7.17 Million
Q1 2020 Apr 17, 2020	SELL	$52.41 - $81.0 $80,711 - $124,740	-1,540 Reduced 4.17%	35,350 $6.67 Million
Q4 2019 Jan 10, 2020	BUY	$71.7 - $82.09 $2.65 Million - $3.03 Million	36,890 New	36,890 $8.61 Million
Q4 2019 Jan 09, 2020	SELL	$71.7 - $82.09 $2.65 Million - $3.04 Million	-36,990 Closed	0 $0
Q3 2019 Oct 21, 2019	SELL	$61.55 - $75.43 $25,235 - $30,926	-410 Reduced 1.1%	36,990 $8.13 Million
Q2 2019 Jul 29, 2019	SELL	$55.74 - $64.41 $87,790 - $101,445	-1,575 Reduced 4.04%	37,400 $6.91 Million
Q1 2019 Apr 22, 2019	SELL	$47.89 - $64.05 $83,280 - $111,382	-1,739 Reduced 4.27%	38,975 $7.46 Million
Q4 2018 Jan 22, 2019	SELL	$46.41 - $56.94 $102,009 - $125,154	-2,198 Reduced 5.12%	40,714 $6.24 Million
Q3 2018 Oct 11, 2018	BUY	$45.7 - $58.03 $9,140 - $11,606	200 Added 0.47%	42,912 $7.47 Million
Q2 2018 Jul 17, 2018	BUY	$42.45 - $51.3 $5,943 - $7,182	140 Added 0.33%	42,712 $6.22 Million
Q1 2018 May 16, 2018	BUY	$37.19 - $47.45 $135,855 - $173,334	3,653 Added 9.39%	42,572 $5.94 Million
Q4 2017 Feb 01, 2018	BUY	$33.79 - $39.39 $313,571 - $365,539	9,280 Added 31.31%	38,919 $4.39 Million
Q3 2017 Oct 16, 2017	BUY	$36.29 - $38.83 $1.08 Million - $1.15 Million	29,639	29,639 $3.24 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.

Account